Content:
Facing ever-growing global health challenges, QL biotech is revolutionizing diagnostic testing with its innovative Influenza A+B/COVID COMBO RAPID TEST, allowing medical professionals to rapidly and accurately diagnose seasonal flu strains together with the COVID-19 virus.
QL biotech, an industry-leading manufacturer and supplier, brings forth an extensive portfolio of rapid test devices. The management and R&D team at QL biotech possess more than 20 years of experience in product development and production within the In-Vitro Diagnostic (IVD) industry. This extensive knowledge and experience in diagnostics have allowed them to develop a diverse range of reliable and accurate testing products.
Their flagship product, the Influenza A+B/COVID COMBO RAPID TEST, has garnered considerable recognition. This convenient test is capable of identifying and differentiating between Influenza A, Influenza B, and COVID-19 simultaneously, enabling healthcare professionals to make more informed clinical decisions quickly. The aim is to streamline and hasten the diagnostic process while maintaining accuracy, especially in the current context when a speedy diagnosis can mean saving lives.
Apart from the Influenza A+B/COVID COMBO RAPID TEST, QL biotech also supplies a variety of other rapid testing devices, accommodating a broad range of clinical needs. Leishmania IgG/IgM Rapid Test Device, Rotavirus/Adenovirus Combo Rapid Test Device, Chlamydia Rapid Test Device, and H.Pylori Ag Rapid Test Device/Strip are some of the high-demand products they manufacture. Each product is designed keeping in mind the high-quality standards, efficiency, and reliability required in medical diagnostics.
Furthermore, QL biotech acknowledges the importance of identifying crucial life stages and has thus developed the HCG One Step Pregnancy Test Device, which can detect pregnancy hormones in both serum and urine. They have also taken into account the ongoing pandemic and introduced a quality-assured COVID-19 Ag Rapid Test kit which is an invaluable product in the global fight against this virus.
In conclusion, QL biotech is a trusted name in the industry, continually producing high-quality, reliable, and quick diagnostic products. Their state-of-the-art Influenza A+B/COVID COMBO RAPID TEST stands as a testament to their innovation and dedication towards improving global health diagnostics. With a knowledgeable and experienced team behind each product, QL biotech ensures that health professionals worldwide can depend on their rapid diagnostic devices for efficient and precise results.
